406 related articles for article (PubMed ID: 27865557)
1. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis.
Doche E; Lecocq A; Maarouf A; Duhamel G; Soulier E; Confort-Gouny S; Rico A; Guye M; Audoin B; Pelletier J; Ranjeva JP; Zaaraoui W
J Neuroradiol; 2017 Mar; 44(2):158-164. PubMed ID: 27865557
[TBL] [Abstract][Full Text] [Related]
2. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
3. Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration.
Laganá MM; Mendozzi L; Pelizzari L; Bergsland NP; Pugnetti L; Cecconi P; Baselli G; Clerici M; Nemni R; Baglio F
Curr Neurovasc Res; 2018; 15(4):282-291. PubMed ID: 30468125
[TBL] [Abstract][Full Text] [Related]
4. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
MacKenzie-Graham A; Kurth F; Itoh Y; Wang HJ; Montag MJ; Elashoff R; Voskuhl RR
JAMA Neurol; 2016 Aug; 73(8):944-53. PubMed ID: 27294295
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Quantitative Cerebral Blood Flow Measurements Performed by Bookend Dynamic Susceptibility Contrast and Arterial Spin-Labeling MRI in Relapsing-Remitting Multiple Sclerosis.
D'Ortenzio RM; Hojjat SP; Vitorino R; Cantrell CG; Lee L; Feinstein A; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2265-2272. PubMed ID: 27686489
[TBL] [Abstract][Full Text] [Related]
6. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis.
Cassiano MT; Lanzillo R; Alfano B; Costabile T; Comerci M; Prinster A; Moccia M; Megna R; Morra VB; Quarantelli M; Brunetti A
Neuroimage Clin; 2020; 26():102201. PubMed ID: 32062567
[TBL] [Abstract][Full Text] [Related]
7. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
[TBL] [Abstract][Full Text] [Related]
8. Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center data.
Datta S; Staewen TD; Cofield SS; Cutter GR; Lublin FD; Wolinsky JS; Narayana PA; ;
Mult Scler Relat Disord; 2015 Mar; 4(2):124-36. PubMed ID: 25787188
[TBL] [Abstract][Full Text] [Related]
9. Multimodal assessment of regional gray matter integrity in early relapsing-remitting multiple sclerosis patients with normal cognition: a voxel-based structural and perfusion approach.
Shooli H; Nemati R; Chabi N; Larvie M; Jokar N; Dadgar H; Gholamrezanezhad A; Assadi M
Br J Radiol; 2021 Nov; 94(1127):20210308. PubMed ID: 34491820
[TBL] [Abstract][Full Text] [Related]
10. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Rudick RA; Lee JC; Nakamura K; Fisher E
J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
[TBL] [Abstract][Full Text] [Related]
11. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
[TBL] [Abstract][Full Text] [Related]
13. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
14. Quantitative T
Harper JG; York EN; Meijboom R; Kampaite A; Thrippleton MJ; Kearns PKA; Valdés Hernández MDC; Chandran S; Waldman AD;
Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
[TBL] [Abstract][Full Text] [Related]
15. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Debernard L; Melzer TR; Van Stockum S; Graham C; Wheeler-Kingshott CA; Dalrymple-Alford JC; Miller DH; Mason DF
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):544-51. PubMed ID: 24039024
[TBL] [Abstract][Full Text] [Related]
16. 3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.
Zhang Y; Metz LM; Yong VW; Mitchell JR
J Neurol Sci; 2010 Oct; 297(1-2):76-81. PubMed ID: 20708201
[TBL] [Abstract][Full Text] [Related]
17. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
18. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
[TBL] [Abstract][Full Text] [Related]
19. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
20. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
